California State Teachers Retirement System (CalSTRS)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,381
| Closed | -$6.97K | – | 3242 |
|
|
2024
Q1 | $6.97K | Sell |
4,381
-2,793
| -39% | -$4.44K | ﹤0.01% | 2966 |
|
|
2023
Q4 | $6.16K | Sell |
7,174
-2,443
| -25% | -$2.1K | ﹤0.01% | 3035 |
|
|
2023
Q3 | $10.3K | Sell |
9,617
-44,579
| -82% | -$47.7K | ﹤0.01% | 3057 |
|
|
2023
Q2 | $140K | Buy |
54,196
+14,104
| +35% | +$36.5K | ﹤0.01% | 2585 |
|
|
2023
Q1 | $164K | Sell |
40,092
-662
| -2% | -$2.7K | ﹤0.01% | 2602 |
|
|
2022
Q4 | $205K | Buy |
40,754
+1,191
| +3% | +$5.98K | ﹤0.01% | 2616 |
|
|
2022
Q3 | $517K | Sell |
39,563
-457
| -1% | -$5.97K | ﹤0.01% | 2315 |
|
|
2022
Q2 | $513K | Sell |
40,020
-87
| -0.2% | -$1.12K | ﹤0.01% | 2387 |
|
|
2022
Q1 | $612K | Sell |
40,107
-3,026
| -7% | -$46.2K | ﹤0.01% | 2311 |
|
|
2021
Q4 | $764K | Buy |
43,133
+758
| +2% | +$13.4K | ﹤0.01% | 2307 |
|
|
2021
Q3 | $891K | Sell |
42,375
-1,081
| -2% | -$22.7K | ﹤0.01% | 2208 |
|
|
2021
Q2 | $857K | Buy |
43,456
+4,651
| +12% | +$91.7K | ﹤0.01% | 2312 |
|
|
2021
Q1 | $1.13M | Buy |
38,805
+2,740
| +8% | +$79.6K | ﹤0.01% | 2073 |
|
|
2020
Q4 | $1.09M | Buy |
36,065
+231
| +0.6% | +$7K | ﹤0.01% | 1981 |
|
|
2020
Q3 | $570K | Buy |
35,834
+438
| +1% | +$6.97K | ﹤0.01% | 2207 |
|
|
2020
Q2 | $699K | Sell |
35,396
-2,333
| -6% | -$46.1K | ﹤0.01% | 2073 |
|
|
2020
Q1 | $465K | Buy |
37,729
+435
| +1% | +$5.36K | ﹤0.01% | 2102 |
|
|
2019
Q4 | $690K | Buy |
37,294
+26,645
| +250% | +$493K | ﹤0.01% | 2173 |
|
|
2019
Q3 | $147K | Buy |
10,649
+295
| +3% | +$4.07K | ﹤0.01% | 2877 |
|
|
2019
Q2 | $152K | Buy |
+10,354
| New | +$152K | ﹤0.01% | 2925 |
|